Editorial
![](/images/Oa.jpg)
Funding considerations for the use of experimental therapies for COVID-19 in the South African private sector
Authors' affiliations
Z Adam, Medscheme Holdings (Pty) Ltd, Cape Town, South Africa
R J Wiseman, Liberty Health (Pty) Ltd, Cape Town, South Africa
Full Text
![](/images/icons/PDF.png)
Cite this article
Article History
Date published: 2020-11-09
Article Views
Full text views: 697
Comments on this article
*Read our policy for posting comments here